To investigate whether SNX-2112 could synergize with TRAIL to suppress human cervical cancer cell viability, a range of cervical cancer cell lines, including HeLa, SiHa, Caski cells, were tested. The gene discussed is TNFSF10; the disease is cervical carcinoma.